Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Sees Significant Decline in Short Interest
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) was the target of a large decrease in short interest in the month of March. As of March 15th, there was short interest totalling 2,690,000 shares, a decrease of 11.5% from the February 29th total of 3,040,000 shares. Based on an average daily volume of 834,900 shares, […]
More Stories
The Sage Group plc (OTCMKTS:SGGEF) Sees Significant Growth in Short Interest
The Sage Group plc (OTCMKTS:SGGEF – Get Free Report) was the recipient of a large increase in short interest during...
Actelis Networks (ASNS) vs. Its Rivals Financial Review
Valuation and Earnings This table compares Actelis Networks and its competitors gross revenue, earnings per share (EPS) and valuation. Gross...
Pinnacle Financial Partners, Inc. (NASDAQ:PNFPP) Short Interest Down 31.0% in November
Pinnacle Financial Partners, Inc. (NASDAQ:PNFPP – Get Free Report) was the target of a large decline in short interest during...
Navigator Holdings Ltd. (NYSE:NVGS) Short Interest Up 53.0% in November
Navigator Holdings Ltd. (NYSE:NVGS – Get Free Report) was the recipient of a significant increase in short interest in November....
TELA Bio, Inc. (NASDAQ:TELA) Short Interest Down 29.8% in November
TELA Bio, Inc. (NASDAQ:TELA – Get Free Report) saw a significant decrease in short interest in November. As of November...
Precipio, Inc. (NASDAQ:PRPO) Short Interest Update
Precipio, Inc. (NASDAQ:PRPO – Get Free Report) was the recipient of a significant decrease in short interest in the month...